Quantum Biopharma Ltd
(QNTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 9,845 | 6,660 | 7,254 | 7,866 | 5,650 |
| Operating Income | -9,845 | -6,660 | -7,254 | -7,866 | -5,650 |
| Interest Expense | 1 | 0 | 16 | 16 | 16 |
| Other Income | -112 | 512 | 141 | -83 | 205 |
| Pre-tax Income | -9,958 | -6,148 | -7,129 | -7,966 | -5,461 |
| Net Income Continuous | -9,958 | -6,148 | -7,129 | -7,966 | -5,461 |
| Net Income Discontinuous | N/A | 0 | N/A | 3,541 | -445 |
| Net Income | $-9,958 | $-6,148 | $-7,129 | $-4,424 | $-5,905 |
| EPS Basic Total Ops | -16.88 | -9.74 | -12.34 | -7.79 | -9.74 |
| EPS Basic Continuous Ops | -16.60 | -10.35 | -12.12 | -13.44 | -8.87 |
| EPS Basic Discontinuous Ops | N/A | -0.06 | N/A | 5.98 | -0.72 |
| EPS Diluted Total Ops | -16.88 | -9.74 | -12.34 | -7.79 | -9.74 |
| EPS Diluted Continuous Ops | -16.60 | -10.35 | -12.12 | -13.44 | -8.87 |
| EPS Diluted Discontinuous Ops | N/A | -0.06 | N/A | 5.98 | -0.72 |
| EBITDA(a) | $-8,715 | $-5,506 | $-6,108 | $-6,733 | $-4,549 |